PharmaEngine Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	2,505	2,523	767.67	654.38	654.84	1,056
Revenue Growth (YoY)	201.12%	228.70%	17.31%	-0.07%	-37.99%	236.27%
Cost of Revenue	48.3	47.74	48.7	49.7	37.07	37.23
Gross Profit	2,457	2,476	718.97	604.68	617.76	1,019
Selling, General & Admin	147.11	155.37	131.51	140.06	118.4	113.35
Research & Development	277.54	267.03	310.28	181.88	136.89	95.73
Operating Expenses	424.66	422.4	441.79	321.95	255.07	209.07
Operating Income	2,032	2,053	277.18	282.74	362.69	809.71
Interest Expense	-0.1	-0.18	-0.31	-0.08	-0.21	-0.44
Interest & Investment Income	92.1	72.14	54.32	25.57	15.42	41.61
Currency Exchange Gain (Loss)	-9.93	37.66	-2.13	8.8	-15.68	-107.06
Other Non Operating Income (Expenses)	-0.21	-	-	0.03	0.31	8.66
EBT Excluding Unusual Items	2,114	2,163	329.06	317.06	362.53	752.48
Gain (Loss) on Sale of Investments	-	-	5.53	45.46	0.82	-
Other Unusual Items	0.21	0.21	3.39	29.95	182.04	-
Pretax Income	2,114	2,163	337.97	392.47	545.4	752.48
Income Tax Expense	439.34	411.97	63.32	73.68	119.36	148.19
Net Income	1,675	1,751	274.65	318.78	426.03	604.28
Net Income to Common	1,675	1,751	274.65	318.78	426.03	604.28
Net Income Growth	352.48%	537.55%	-13.84%	-25.17%	-29.50%	1320.17%
Shares Outstanding (Basic)	144	144	144	144	145	146
Shares Outstanding (Diluted)	144	144	144	144	145	146
Shares Change (YoY)	0.17%	0.13%	0.03%	-0.72%	-0.80%	0.11%
EPS (Basic)	11.66	12.19	1.91	2.22	2.95	4.15
EPS (Diluted)	11.63	12.17	1.91	2.22	2.94	4.14
EPS Growth	352.68%	537.17%	-13.96%	-24.49%	-28.99%	1327.59%
Free Cash Flow	1,719	455.92	256.56	198.57	929.44	64.77
Free Cash Flow Per Share	11.94	3.17	1.78	1.38	6.42	0.44
Dividend Per Share	6.000	6.000	1.500	2.000	2.700	2.500
Dividend Growth	300.00%	300.00%	-25.00%	-25.93%	8.00%	400.00%
Gross Margin	98.07%	98.11%	93.66%	92.41%	94.34%	96.47%
Operating Margin	81.12%	81.37%	36.11%	43.21%	55.39%	76.68%
Profit Margin	66.86%	69.39%	35.78%	48.72%	65.06%	57.22%
Free Cash Flow Margin	68.63%	18.07%	33.42%	30.34%	141.94%	6.13%
EBITDA	2,034	2,055	278.55	283.44	363.39	811.29
EBITDA Margin	81.19%	81.43%	36.29%	43.31%	55.49%	76.83%
D&A For EBITDA	1.78	1.65	1.37	0.71	0.7	1.58
EBIT	2,032	2,053	277.18	282.74	362.69	809.71
EBIT Margin	81.12%	81.37%	36.11%	43.21%	55.39%	76.68%
Effective Tax Rate	20.78%	19.05%	18.74%	18.77%	21.89%	19.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.